InvestorsHub Logo
Followers 3
Posts 207
Boards Moderated 0
Alias Born 09/01/2016

Re: rudygerner post# 74388

Tuesday, 08/29/2017 8:25:31 AM

Tuesday, August 29, 2017 8:25:31 AM

Post# of 144814
Rudy,

Here are the last 3 appointments to PharmaCyte's Team and their opening statements about the company and CIAB:

Commenting on her appointment, Dr. Sher said, "I am joining PharmaCyte at a major inflection point in the company's evolution as a biotech company with potentially game-changing technology in the way solid tumors are treated. This is an exciting time for PharmaCyte, and I am pleased that I have been asked to play such a major and important role in the company."

Commenting on his appointment, Dr. Abecassis said, "I too am excited to join PharmaCyte's Board. This is a company built upon a cellular platform technology that is transformational in nature. The opportunities for growth in cellular therapies to treat diseases are limitless. The Cell-in-a-Box(R) technology appears to be an ideal vehicle to capitalize on these opportunities."

Mr. Yuen commented, "I am very pleased to become a member of PharmaCyte's Board of Directors. PharmaCyte is a dynamic and exciting company with a transformative platform technology. There are a multitude of opportunities for growth in cell therapies, and I intend to play a significant role in helping PharmaCyte achieve its business goals."



This is pretty cool that 3 big players are all so optimistic about this technology.

They are all in agreement that CIAB is potentially "transformational", "transformative" "game-changing" "inflection point".

Would everyone agree that they wouldn't come on board a ship that wasn't headed for the open seas?

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News